Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells

被引:28
|
作者
Ronchetti, A
Iezzi, G
Crosti, MC
Garancini, MP
Protti, MP
Bellone, M
机构
[1] Ist Sci H San Raffaele, Lab Immunol Tumori, I-20132 Milan, Italy
[2] Ist Sci H San Raffaele, Unita Immunochim, I-20132 Milan, Italy
[3] Ist Sci H San Raffaele, Unita Epidemiol, I-20132 Milan, Italy
[4] Ist Sci H San Raffaele, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy
关键词
in vivo animal models; cancer immunity; RMA; ovalbumin; apoptosis;
D O I
10.1002/jlb.66.2.247
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the mechanisms regulating recognition and phagocytosis of apoptotic cells by scavenger cells ape the subject of intense investigation, little is known about the fate of the antigens contained in apoptotic cells and the constraints defining their immunogenicity, We developed a model in C57BL/6 mice to evaluate whether phagocytosis of apoptotic tumor cells yielded antigens able to get access to the MHC class I pathway and activate a specific cytotoxic T lymphocyte response. Our results demonstrate that apoptotic tumor cells are antigenic in, vitro and can be immunogenic in vivo. Their immunogenicity depends on the number of cells used for immunization and the antigen-presenting cells involved in processing and presentation of antigens contained in the dying cells. The demonstration of the immunogenicity of apoptotic cells may have direct implications both in autoimmunity and cancer.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 50 条
  • [31] Generation of allo-restricted cytotoxic T lymphocytes against malignant glioma by artificial antigen-presenting cells
    Lu, Xiao-ling
    Jiang, Xiao-bing
    Liu, Ru-en
    Zhang, Fang-cheng
    Zhao, Hong-yang
    CANCER LETTERS, 2007, 256 (01) : 128 - 135
  • [32] Cytotoxic T lymphocyte activation by cross-priming
    Heath, WR
    Carbone, FR
    CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (03) : 314 - 318
  • [33] ANTIGEN-PRESENTING CELLS FOR UNPRIMED T-CELLS
    SPRENT, J
    SCHAEFER, M
    IMMUNOLOGY TODAY, 1989, 10 (01): : 17 - 23
  • [34] Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens
    Lenz, LL
    Butz, EA
    Bevan, MJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08): : 1135 - 1142
  • [35] Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes
    Fu, TM
    Ulmer, JB
    Caulfield, MJ
    Deck, RR
    Friedman, A
    Wang, S
    Liu, X
    Donnelly, JJ
    Liu, MA
    MOLECULAR MEDICINE, 1997, 3 (06) : 362 - 371
  • [36] Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes
    Tong-Ming Fu
    Jeffrey B. Ulmer
    Michael J. Caulfield
    R. Randall Deck
    Arthur Friedman
    Su Wang
    Xu Liu
    John J. Donnelly
    Margaret A. Liu
    H. Wigzell
    Molecular Medicine, 1997, 3 : 362 - 371
  • [37] Transfusion tickles T cells through cross-priming
    Gorham, JD
    BLOOD, 2006, 107 (01) : 6 - 7
  • [38] Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness
    Ferguson, TA
    Herndon, J
    Elzey, B
    Griffith, TS
    Schoenberger, S
    Green, DR
    JOURNAL OF IMMUNOLOGY, 2002, 168 (11): : 5589 - 5595
  • [39] Activation of regulatory T cells via cross-priming
    Smith, TR
    Maricic, I
    Pedersen, B
    Kumar, V
    FASEB JOURNAL, 2005, 19 (04): : A413 - A413
  • [40] Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity
    Ngo, Minhtran Charlotte
    Ando, Jun
    Leen, Ann M.
    Ennamuri, Sravya
    Lapteva, Natalia
    Vera, Juan F.
    Min-Venditti, Amelia
    Mims, Martha P.
    Heslop, Helen E.
    Bollard, Catherine M.
    Gottschalk, Stephen
    Rooney, Cliona M.
    JOURNAL OF IMMUNOTHERAPY, 2014, 37 (04) : 193 - 203